295 related articles for article (PubMed ID: 31707797)
1. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Impact of Biomarker-Guided Versus ASCVD Risk-Guided Drug Treatment in US Adults With Stage 1 Hypertension: The National Health and Nutrition Examination Survey, 1999 to 2004.
Foti K; Wang D; Tang O; Daya NR; Commodore-Mensah Y; Juraschek SP; Christenson RH; Selvin E; McEvoy JW
Hypertension; 2024 Jul; 81(7):1599-1608. PubMed ID: 38690651
[TBL] [Abstract][Full Text] [Related]
3. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
[TBL] [Abstract][Full Text] [Related]
4. 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
Colantonio LD; Booth JN; Bress AP; Whelton PK; Shimbo D; Levitan EB; Howard G; Safford MM; Muntner P
J Am Coll Cardiol; 2018 Sep; 72(11):1187-1197. PubMed ID: 30189994
[TBL] [Abstract][Full Text] [Related]
5. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
[TBL] [Abstract][Full Text] [Related]
6. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
Yano Y; Reis JP; Colangelo LA; Shimbo D; Viera AJ; Allen NB; Gidding SS; Bress AP; Greenland P; Muntner P; Lloyd-Jones DM
JAMA; 2018 Nov; 320(17):1774-1782. PubMed ID: 30398601
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.
Jaeger BC; Anstey DE; Bress AP; Booth JN; Butler M; Clark D; Howard G; Kalinowski J; Long DL; Ogedegbe G; Plante TB; Shimbo D; Sims M; Supiano MA; Whelton PK; Muntner P
Hypertension; 2019 Feb; 73(2):327-334. PubMed ID: 30595115
[TBL] [Abstract][Full Text] [Related]
8. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
[TBL] [Abstract][Full Text] [Related]
9. Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.
McEvoy JW; Daya N; Rahman F; Hoogeveen RC; Blumenthal RS; Shah AM; Ballantyne CM; Coresh J; Selvin E
JAMA; 2020 Jan; 323(4):329-338. PubMed ID: 31990314
[TBL] [Abstract][Full Text] [Related]
10. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
Bress AP; Colantonio LD; Cooper RS; Kramer H; Booth JN; Odden MC; Bibbins-Domingo K; Shimbo D; Whelton PK; Levitan EB; Howard G; Bellows BK; Kleindorfer D; Safford MM; Muntner P; Moran AE
Circulation; 2019 Jan; 139(1):24-36. PubMed ID: 30586736
[TBL] [Abstract][Full Text] [Related]
11. Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
J Am Coll Cardiol; 2018 Jan; 71(2):109-118. PubMed ID: 29146532
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
13. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
Shafi T; Zager PG; Sozio SM; Grams ME; Jaar BG; Christenson RH; Boulware LE; Parekh RS; Powe NR; Coresh J
Am J Kidney Dis; 2014 Sep; 64(3):443-51. PubMed ID: 24787760
[TBL] [Abstract][Full Text] [Related]
14. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
15. The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Welsh P; Poulter NR; Chang CL; Sever PS; Sattar N;
Hypertension; 2014 Mar; 63(3):507-13. PubMed ID: 24324046
[TBL] [Abstract][Full Text] [Related]
16. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
Hussain A; Sun W; Deswal A; de Lemos JA; McEvoy JW; Hoogeveen RC; Matsushita K; Aguilar D; Bozkurt B; Virani SS; Shah AM; Selvin E; Ndumule C; Ballantyne CM; Nambi V
J Am Coll Cardiol; 2021 Feb; 77(5):559-571. PubMed ID: 33538254
[TBL] [Abstract][Full Text] [Related]
17. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
Circulation; 2018 Oct; 138(17):e595-e616. PubMed ID: 30354656
[TBL] [Abstract][Full Text] [Related]
19. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
20. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
